
Vy Capital
Emirates Financial Towers, South Tower, Level 9, Office 901/902, DIFC, Dubai, 506950, United Arab Emirates
Overview
Vy Capital is an investment firm that focuses on the internet and software industry. It was founded in 2013 by Alexander Tamas and is headquartered in Dubai, United Arab Emirates.
- Total investments
- 51
- Lead investments
- 12
- Investments · 12mo
- 4
- Active investors
- 3
Sector focus
- Enterprise Software
- Financial Services
- Online Portals
- Venture Capital
Investment portfolio
- Neuralink
Participated · Series E · May 2026
Neuralink develops implantable brain-computer interface devices that decode neural signals to enable control of phones, computers and other systems. The company is conducting first human trials across three countries and reports that five patients with severe paralysis are using its device to control digital and physical systems by thought alone. Regulators have granted its speech restoration system a Breakthrough Device designation from the FDA, and the company previously received a similar designation for a vision-restoring implant. Financially, Neuralink announced a $650 million capital raise with participation from multiple top-tier investors, and reports earlier financing of $600 million at a reported $9 billion valuation. The company says the funds will be used to expand clinical testing and bring its technology to more people with unmet medical needs.
- Counterpart
Participated · Series C · Apr 2026
Counterpart builds an operating system for business risk and markets Agentic Insurance, which combines deep insurance expertise with AI to provide management and professional liability solutions for brokers and the businesses they serve. The company is led by CEO and founder Tanner Hackett and is based in Los Angeles, CA. Following its $50M Series C, Counterpart has raised $106M in total funding. The firm plans to use the new capital to launch new specialty insurance products, create industry-specific programs, and expand claims and risk management capabilities. The company positions its offerings for brokers and businesses facing critical exposures. No revenue, user, or valuation figures were disclosed in the article.
- Neros Technologies
Participated · Series B · Nov 2025
Neros Technologies develops and manufactures a range of small, mass-produced military drones including FPV platforms with autonomy and counter-UAS interceptor systems. The company announced new products Archer AI (an FPV platform augmented with autonomy features) and Bandit (a c‑UAS interceptor) and is building the hardware and compute stack for multi-asset control. Neros plans to scale domestic production capacity and aims to produce one million drones per year across multiple capability classes by 2028. It has major contracts with the U.S. Army, Marine Corps, every component of SOCOM, and several allied nations, and operates a UK subsidiary to partner with European allies. Management reported explosive growth since its prior financing in November and is using fresh capital to accelerate development, production ramps, and deployment into combat theaters by the end of 2026. The company is headquartered in Torrance, Calif.
- OneImaging
Led · Series A · Oct 2025
OneImaging offers an end-to-end digital platform that handles scheduling, prior authorization, insurance, pricing, and results delivery for medical imaging. By steering patients to its national network of accredited imaging centers, the company claims to cut imaging costs by up to 80 % while maintaining high quality of care. Employers use the service to curb rising healthcare spend, and the platform’s automated workflows reportedly lower partner imaging centers’ operating expenses by 30 % and reduce appointment cancellations from roughly 25 % to 1 %. In less than three years, OneImaging says it has grown 50× and now serves two million covered lives through integrations with major commercial health plans and relationships with multiple Fortune 100 employers. Key product features include upfront price transparency, real-time provider reimbursement, and financing options that shorten the traditional revenue-cycle timeline from months to instant payment. Founded by Elan Adler—whose prior experience spans Siemens Healthineers and the Cleveland Clinic—the company positions itself as the "magic pill" for affordable imaging. The platform addresses a large market need, as one in two Americans require imaging each year and high prices cause 37 % of patients to delay or skip care.
- xAI
Participated · Series C · Dec 2024
xAI develops state-of-the-art artificial-intelligence models and related platform technology, positioning itself as a frontier provider of advanced AI capabilities. The company’s Grok models are slated for deployment in Saudi Arabia through a 500 MW joint data-center and compute-infrastructure initiative with strategic partner HUMAIN. xAI is on the cusp of being acquired by SpaceX, a transaction that will marry its AI expertise with SpaceX’s global scale and engineering resources. The merger is expected to accelerate product integration and platform expansion across both terrestrial and space-oriented applications. Financially, xAI just closed a multi-billion-dollar Series E round, its final fundraising before the SpaceX acquisition, reinforcing investor confidence in its technology and growth trajectory. HUMAIN’s investment converts into SpaceX equity upon completion of the merger, providing continuity of long-term capital support for xAI’s roadmap.